Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Anti-tnf Inhibitor Antibody-mediated Blockade Of Drug Efficacy In Rheumatoid Arthritis (Antibody-ra)

NCT01981473 is registered in ClinicalTrials.gov with Pfizer as lead sponsor.

NCT NCT01981473
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01981473 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Anti-tnf Inhibitor Antibody-mediated Blockade Of Drug Efficacy In Rheumatoid Arthritis (Antibody-ra)
Lead sponsor
Pfizer
Phase
Observational
Overall status
Completed
Start date
January 31, 2014
Completion date
December 31, 2014
Enrollment
605 (actual)
Sites
54

Conditions

As the registry lists them; a condition with its own page is linked.

rheumatoid arthritis